Is Novavax Stock a Buy?
I make bad calls on stocks more frequently than I'd like. The good news is that an investor can be wrong fairly often and yet still do well overall if their winners deliver exceptionally strong gains. Novavax (NASDAQ: NVAX) is one stock that I made the right call on; it's been a huge winner.
As far back as March 2018, I wrote that "if you're willing to take on risk, buying a small position in Novavax could pay off in a big way." Throughout 2020, I sang Novavax's praises. The stock ended up becoming one of the best-performing stocks last year with a 2,700% gain. It's more than doubled so far in 2021.
Is Novavax stock still a buy after this tremendous performance? The answer to this question depends on the same factors that applied in 2018 through 2020: the biotech's growth prospects and its risks.
Source Fool.com
